96 related articles for article (PubMed ID: 15883619)
1. TIRC7 pathway as a target for preventing allograft rejection.
Tamura A; Milford EL; Utku N
Drug News Perspect; 2005 Mar; 18(2):103-8. PubMed ID: 15883619
[TBL] [Abstract][Full Text] [Related]
2. T-cell immune response cDNA 7 in allograft rejection and inflammation.
Utku N; Heinemann T; Milford EL
Curr Opin Investig Drugs; 2007 May; 8(5):401-10. PubMed ID: 17520869
[TBL] [Abstract][Full Text] [Related]
3. TIRC7 is induced in rejected human kidneys and anti-TIRC7 mAb with FK506 prolongs survival of kidney allografts in rats.
Kumamoto Y; Tamura A; Volk HD; Reinke P; Löhler J; Tullius SG; Utku N
Transpl Immunol; 2006 Nov; 16(3-4):238-44. PubMed ID: 17138060
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody specific for TIRC7 induces donor-specific anergy and prevents rejection of cardiac allografts in mice.
Kumamoto Y; Tomschegg A; Bennai-Sanfourche F; Boerner A; Kaser A; Schmidt-Knosalla I; Heinemann T; Schlawinsky M; Blumberg RS; Volk HD; Utku N
Am J Transplant; 2004 Apr; 4(4):505-14. PubMed ID: 15023142
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of T cell homing by down-regulation of CD62L and the induction of a Th-2 response as a method to prevent acute allograft rejection in mice.
Stremmel C; Sienel W; Eggeling S; Passlick B; Slavin A
Eur J Cardiothorac Surg; 2006 Aug; 30(2):362-9. PubMed ID: 16828564
[TBL] [Abstract][Full Text] [Related]
6. Prevention of acute allograft rejection by antibody targeting of TIRC7, a novel T cell membrane protein.
Utku N; Heinemann T; Tullius SG; Bulwin GC; Beinke S; Blumberg RS; Beato F; Randall J; Kojima R; Busconi L; Robertson ES; Schülein R; Volk HD; Milford EL; Gullans SR
Immunity; 1998 Oct; 9(4):509-18. PubMed ID: 9806637
[TBL] [Abstract][Full Text] [Related]
7. Genomic organization of the gene coding for TIRC7, a novel membrane protein essential for T cell activation.
Heinemann T; Bulwin GC; Randall J; Schnieders B; Sandhoff K; Volk HD; Milford E; Gullans SR; Utku N
Genomics; 1999 May; 57(3):398-406. PubMed ID: 10329006
[TBL] [Abstract][Full Text] [Related]
8. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 7 receptor alpha as a potential therapeutic target in transplantation.
Racapé M; Vanhove B; Soulillou JP; Brouard S
Arch Immunol Ther Exp (Warsz); 2009; 57(4):253-61. PubMed ID: 19585222
[TBL] [Abstract][Full Text] [Related]
10. Antibody targeting of TIRC7 results in significant therapeutic effects on collagen-induced arthritis in mice.
Utku N; Heinemann T; Winter M; Bulwin CG; Schlawinsky M; Fraser P; Nieuwenhuis EE; Volk HD; Blumberg RS
Clin Exp Immunol; 2006 Apr; 144(1):142-51. PubMed ID: 16542376
[TBL] [Abstract][Full Text] [Related]
11. Regulation of B- and T-cell mediated xenogeneic transplant rejection by interleukin 12.
Hosiawa KA; Wang H; DeVries ME; Garcia B; Jiang J; Zhou D; Cameron MJ; Zhong R; Kelvin DJ
Transplantation; 2006 Jan; 81(2):265-72. PubMed ID: 16436971
[TBL] [Abstract][Full Text] [Related]
12. TIRC7 inhibits T cell proliferation by modulation of CTLA-4 expression.
Bulwin GC; Heinemann T; Bugge V; Winter M; Lohan A; Schlawinsky M; Schulze A; Wälter S; Sabat R; Schülein R; Wiesner B; Veh RW; Löhler J; Blumberg RS; Volk HD; Utku N
J Immunol; 2006 Nov; 177(10):6833-41. PubMed ID: 17082597
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of intragraft and peripheral blood TIRC7 expression as a diagnostic tool for acute cardiac rejection in humans.
Shulzhenko N; Morgun A; Rampim GF; Franco M; Almeida DR; Diniz RV; Carvalho AC; Gerbase-DeLima M
Hum Immunol; 2001 Apr; 62(4):342-7. PubMed ID: 11295466
[TBL] [Abstract][Full Text] [Related]
14. TIRC7 deficiency causes in vitro and in vivo augmentation of T and B cell activation and cytokine response.
Utku N; Boerner A; Tomschegg A; Bennai-Sanfourche F; Bulwin GC; Heinemann T; Loehler J; Blumberg RS; Volk HD
J Immunol; 2004 Aug; 173(4):2342-52. PubMed ID: 15294947
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
[TBL] [Abstract][Full Text] [Related]
17. Asialo GM1 positive CD8+ T cells induce skin allograft rejection in the absence of the secondary lymphoid organs.
Yamanokuchi S; Ikai I; Nishitai R; Matsushita T; Sugimoto S; Shiotani T; Yamaoka Y
J Surg Res; 2005 Nov; 129(1):57-63. PubMed ID: 16140338
[TBL] [Abstract][Full Text] [Related]
18. Antibody-mediated rejection: treatment alternatives and outcomes.
Singh N; Pirsch J; Samaniego M
Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of costimulatory pathway modulation on corneal allograft survival.
Watson MP; George AJ; Larkin DF
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3417-22. PubMed ID: 16877411
[TBL] [Abstract][Full Text] [Related]
20. TIRC7 inhibits Th1 cells by upregulating the expression of CTLA‑4 and STAT3 in mice with acute graft‑versus‑host disease.
Zhu F; Qiu T; Zhu S; Zhao K; Chen C; Qiao J; Pan B; Yan Z; Chen W; Liu Q; Wu Q; Cao J; Sang W; Zeng L; Sun H; Li Z; Xu K
Oncol Rep; 2020 Jul; 44(1):43-54. PubMed ID: 32319655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
